Chương 5. KẾT LUẬN VÀ ĐỀ XUẤT 5.1. Kết luận

TÀI LIỆU THAM KHẢO

1. Bộ môn Dược lâm sàng (2007), Dược lâm sàng và điều trị, ĐH Dược Hà Nội.

2. Bộ môn Dược lâm sàng, Trường đại học Dược Hà Nội (2006), Dược lâm sàng, NXB Y học.

3. Bộ Y tế (2009), Dược thư Quốc gia Việt Nam 2009, NXB Y học.

4. Bộ Y tế (2009), Thông tư 13/2009/TT-BYT: Hướng dẫn hoạt động thông tin quảng cáo thuốc.

5. Bộ Y tế (2008), Thông tư 04/2008/TT-BYT: Hướng dẫn ghi nhãn thuốc.

6. CMP Medica (2011), Mims Cẩm nang nhà thuốc thực hành.

7. CMP Medica (2010), Mims Cẩm nang sử dụng thuốc.

8. CMP Medica (2010), Vidal Việt Nam.

9. Nguyễn Thị Vân Anh (2010), "Khảo sát các loại hình câu hỏi thông tin thuốc thường gặp trên lâm sàng, Bệnh viện Bạch Mai", Khóa luận tốt nghiệp Dược sĩ, Trường Đại học Dược Hà Nội.

10. Phạm Thiệp, Vũ Ngọc Thúy (2010), Thuốc biệt dược và cách sử dụng, NXB Y học.

11. Trung tâm DI & ADR Quốc gia (2009), "Đánh giá năng lực Quốc gia về thông tin thuốc và cảnh giác dược ", Báo cáo kỹ thuật dự án gửi Văn phòng Tổ chức Y tế Thế giới tại Việt Nam.

12. Alloza JL, Lasagna L (1983), "A comparison of drug information in four national compendia", Clinical Pharmacology and Therapeutics, 3(3), pp. 269-277.

13. American hospital formulary service (2010), AHFS Drug Information 2010.

14. Anderson PO, McGuinness SM (2009), "Tertiary Information Sources for Professionals and Patients", Pharmacy Informatics, Taylor and Francis.

15. Arguello B, Fernandez - Llimos (2007), "Clinical Pharmacology information in summaries of product characteristics and package inserts", Clinical Pharmacology and Therapeutics, 82(5), pp. 566-571.

16. Bajracharya O, Shankar PR et al (2009), "Need for medicine (drug) information services in a teaching hospital", The clinical researcher, 1(2), pp. 58-63.

17. Bond CA, Raelh Cl, Franke T (2002), "Clinical pharmacy services, hospital pharmacy staffing and medication errors in United States hospitals", Pharmacotherapy, 22, pp. 134-147.

18. Brier ME, Aronoff GR (2007), Drug Prescribing in Renal Failure.

19. Clauson KA (2008), "Pharmacists: Are Your Drug Information Databases Accurate?" US Pharmacist.

20. Clauson KA, Seamon MJ, Clauson AS et al (2004), "Evaluation of drug information databases for personal digital assistants", American Journal of Health- System Pharmacist, 61, pp. 1015-1024.

21. Cohen JS (2001), "Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference." Archives of Internal Medicine, 161, pp. 880-885.

22. Fusier I, Tollier C, Husson MC (2004), "Infovigilance: reporting errors in offical drug information sources", Pharm World Sci, 27, pp. 166-169.

23. Gabardi S, Abramson S (2005), "Drug dosing in chronic kidney disease ", The Medical Clinics of North America, 89, pp. 649-687.

24. Giovenale S (2008), RESEARCH GUIDE Drug Information – General, University of Connecticut.

25. Hands D, Stephens M, Brown D (2002), "A systemic review of the clinical and economic impact of drug information services on patient outcome", Pharmacy World & Science, 24(4), pp. 132-138.

26. Keller F, Giehl M et al (1995), "Pharmacokinetics and drug dosage adjustment to renal impairment ", Nephrol Dial Transplant 1995, pp. 1516-1520.

27. Lacy CF, Amstrong LL et al (2009-2010), Drug Information Handbook, Lexi-Comp Inc.

28. Leape LL, Bates DW, Culelen DJ et al (1995), "Systems analysis of adverse drug event", The journal of American Medical Association, 274, pp. 35-43.

29. Lowry CM, Kostka-Rokosz MD, McCloskey WW (2003), "Evalution of personal digital assistant drug information databases for the managed care pharmacist", J Managed Care Pharm, 9, pp. 441-448.

30. Malone PM, Kier KL, Stanovich JE (2007), "Introduction to the Concept of Medication Information", Drug Information: A Guide for Pharmacists 3rd edition, The McGraw-Hill Companies.

31. Malone PM, Kier KL, Stanovich JE (2007), "Drug Information Resources ", Drug Information: A Guide for Pharmacists 3rd edition, The McGraw-Hill Companies.

32. Marroum PJ, Gobburu J (2002), "The Product Label: How Pharmacokinetics and Pharmacodynamics reach the prescriber", Clin Pharmacokinet, 41(3), pp. 161-169.

33. Martin-Facklam M, Rengelshausen J et al (2004), "Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?" Eur J Clin Pharmacol, 60, pp. 807-811.

34. Martin J et al (2009), British National Formulary.

35. Moroney A (2007), "Dose-Response Relationships", The Merck Manuals of diagnosis and therapy 18th edition, Merck & CO., Inc, pp.

36. Munar MY, Singh H (2007), "Drug dosing adjustment in patient with chronic kidney disease", American Academy of Family Physicians, 75, pp. 1487-1496.

37. Permala J, Hassali MA et al (2010), "Dosing information in a standard drug reference: Are pediatrics still therapeutically neglected?" Pediatrics International 52, pp. 290-295.

38. Reggi V, Balocco-Mattavelli R, Bonati M et al (2003), "Prescribing information in 26 countries: a comparative study", Eur J Clin Pharmacol, 59, pp. 263-270.

39. Saito M, Hirata-Koizumi M et al (2005), "A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan", Journal of Clinical Pharmacy and Therapeutics, 30, pp. 21-37.

40. Shirkey H (1968), "Therapeutic orphans", J. Pediatr, 72, pp. 119-120.

41. Spyker DA, Harvey ED et al (1999), "Assessment and reporting of clinical pharmacology information in drug labeling", Clinical Pharmacology and Therapeutics, 67, pp. 196-200.

42. Steinmetz KL, Coley KC , Pollock BG (2005), "Assessment of geriatric information on the drug label for commonly prescribed drugs in older people", Journal of the American Geriatrics Society, 53, pp. 891-894.

43. Sweetman SC (2009), Martindale: The Complete Drug Reference, The Pharmaceutical Press.

44. Tan E, Cranswick NE et al (2003), "Dosing information for paediatric patients: are they really "therapeutic orphans"?" Medical Journal of Australia 179, pp. 195-198.

45. van Dijk EA, Drabbe NR et al (2006), "Drug dosage adjustment according to renal function at hospital discharge", The Annals of Pharmacotherapy, 40, pp. 1254-1260.

46. Vidal Liat, Shavit M et al (2005), "Systematic comparison of four sources of drug information regarding adjustment of dose for renal function", Bristish Medical Journal, 331, pp. 263-266.

47. Wong PS, Ko Y, Sklar GE (2009), "Indentification and evalution of pharmacists's commonly used drug information sources", The Annals of Pharmacotherapy, 43, pp. 347-352.
Tiếng Pháp

48. Les équipes scientifique et éditoriale VIDAL (2010), Dictionaire du Vidal, Édition VIDAL.

49. http://Mims.com/